About
Ximing joined Pureos Bioventures in 2018. Prior to Pureos, he was a Post-Doc at the European Molecular Biology Laboratory in Heidelberg, Germany. Ximing is currently a BoD observer at Araris Biotech, Engimmune Therapeutics and Tridek-One. Ximing obtained his PhD at the European Molecular Biology Laboratory and holds an MSc. in Biology at ETH Zurich.
Sign up to see Dr. Ximing Ding's full profile
Access investment thesis, focus areas, bio, and contact details for Dr. Ximing Ding and 22,000+ other VC professionals.
Pureos Bioventures
Pfäffikon, CH